Browsing Infectious Diseases Institute (IDI) by Title "Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis"
Now showing items 1-1 of 1
-
Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis
(Public Library of Science, 2012-06)Background: In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid ...